weightwatchers glp-1 program glp 1 Launches New Behavior Change Program Designed to Support the Unique Needs of Weight Watchers Program Changes in

The impact of these medications is proving to go beyond traditional uses to significantly improve key health metrics from metabolic health to glucose regulation, liver function34, heart health and even sleep56 that could be foundational to a long, healthy life and a key driver in longevity. The drops come in both Tirzepatide and semaglutide forms

increased risk of kidney, pancreas and gastrointestinal problems Getty Images Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a recent study reporting one in eight Americans has taken or is currently using the drugs to treat diabetes, heart disease or obesity

As people lose weight, they may need less medication to maintain the same effect

Wegovy is approved for people with obesity (BMI 30 or higher) or overweight (BMI 27 or higher) with weight-related conditions